Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin.

× No keyword cloud information.

12 in total

1. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors: D W BARRITT; S C JORDAN
Journal: Lancet Date: 1960-06-18 Impact factor: 79.321

2. Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease.

Authors: W Klein; A Buchwald; W S Hillis; S Monrad; G Sanz; A G Turpie; J van der Meer; E Olaisson; S Undeland; K Ludwig
Journal: Am J Cardiol Date: 1997-09-04 Impact factor: 2.778

3. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.

Authors: A J Palmer; K Koppenhagen; B Kirchhof; U Weber; R Bergemann
Journal: Haemostasis Date: 1997 Mar-Apr

4. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.

Authors: A Oler; M A Whooley; J Oler; D Grady
Journal: JAMA Date: 1996-09-11 Impact factor: 56.272

5. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

Authors: W H Geerts; R M Jay; K I Code; E Chen; J P Szalai; E A Saibil; P A Hamilton
Journal: N Engl J Med Date: 1996-09-05 Impact factor: 91.245

6. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

Authors: R D Hull; G E Raskob; G F Pineo; D Green; A A Trowbridge; C G Elliott; R G Lerner; J Hall; T Sparling; H R Brettell
Journal: N Engl J Med Date: 1992-04-09 Impact factor: 91.245

7. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

Authors: M Levine; M Gent; J Hirsh; J Leclerc; D Anderson; J Weitz; J Ginsberg; A G Turpie; C Demers; M Kovacs
Journal: N Engl J Med Date: 1996-03-14 Impact factor: 91.245

8. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

Authors: M M Koopman; P Prandoni; F Piovella; P A Ockelford; D P Brandjes; J van der Meer; A S Gallus; G Simonneau; C H Chesterman; M H Prins
Journal: N Engl J Med Date: 1996-03-14 Impact factor: 91.245

9. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.

Authors: E M Antman
Journal: Circulation Date: 1996-09-01 Impact factor: 29.690

10. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.

Authors: A W Lensing; M H Prins; B L Davidson; J Hirsh
Journal: Arch Intern Med Date: 1995-03-27

1 in total

1. The end of the heparin pump? Dosage regimens for low molecular weight heparins differ.

Authors: M Lloyd
Journal: BMJ Date: 1999-08-28

1 in total